We innovate with a focus on three therapeutic areas - oncology, gastroenterology (GI), and neuroscience. We also leverage world-class capabilities to develop vaccines to address critical public health threats using novel development platforms and collaboration with leading partners.
Neuropsychiatric disorders are complex, multifaceted conditions that affect the spectrum of mental health. We aspire to provide innovative medicines for targeted patient populations suffering from neuropsychiatric disorders for whom there are no treatments available.
For more than 25 years, Takeda has focused on improving the lives of patients through the delivery of innovative medicines and dedicated patient disease support programs in gastroenterology (GI). Takeda is leading in areas of GI associated with high unmet need, such as inflammatory bowel disease, GI acid-related diseases, and GI motility disorders.
We endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies.
Please visit takedaoncology.com for more information.
Vaccines have transformed global public health. Our world-class vaccine team is addressing unmet medical needs through vaccine development against infectious diseases, while using innovative development platforms and collaborating with leading partners.